DalsnaFinance › IPOs › Genmab A/s › IPO
GENMAB A/S completed its initial public offering on NASDAQ on July 18, 2019, pricing at $17.75 a share.
| Ticker | GMAB |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | July 18, 2019 |
| Offering price | $17.75 |
| Shares offered | 28,500,000 |
| Total raised | $506M |
GENMAB A/S sold 28,500,000 shares at $17.75 each on NASDAQ. Multiplied out, that is $505.9 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $506 million total recorded for the deal.
GENMAB A/S — quote, profile and latest news →
Source: SEC EDGAR filings for GENMAB A/S. This page is general information, not investment advice.